Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer

Clinical trial NCT06962137 · RECRUITING

Trial details

NCT number: NCT06962137
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Adenocarcinoma Metastatic Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

Start date: 2025-12-11
Primary completion: 2029-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.